Related Experiment Video
Updated: Nov 4, 2025
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.8K
Sickle cell nephropathy: insights into the pediatric population
Oyindamola C Adebayo1,2, Lambertus P Van den Heuvel1,3, Wasiu A Olowu4
1Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.
Pediatric Nephrology (Berlin, Germany)
|May 29, 2021
Summary
Improved care increases sickle cell disease survival, but sickle cell nephropathy (SCN) is a growing concern. This review focuses on SCN in children, detailing its causes, effects, and management.
Area of Science:
- Nephrology
- Hematology
- Pediatrics
Background:
- Improved diagnosis and medical care have increased life expectancy for individuals with sickle cell disease.
- Increased longevity has led to a higher prevalence of chronic complications, notably sickle cell nephropathy (SCN).
- Sickle cell nephropathy significantly impacts patient lifespan, reducing it by 20-30 years.
Purpose of the Study:
- To review the epidemiology, pathology, pathophysiology, clinical presentation, and management of sickle cell nephropathy (SCN).
- To focus specifically on the pediatric population affected by SCN.
- To discuss factors influencing SCN susceptibility.
Main Methods:
- Literature review and synthesis of existing research on sickle cell nephropathy.
- Analysis of age-dependent clinical presentations of SCN.
- Exploration of epidemiological data and risk factors.
Main Results:
- Sickle cell nephropathy (SCN) develops progressively from childhood, leading to chronic kidney disease and failure in adulthood.
- Clinical manifestations of SCN are age-dependent.
- Understanding SCN susceptibility factors is crucial for early intervention.
Conclusions:
- Sickle cell nephropathy (SCN) is a critical complication of sickle cell disease, requiring focused management strategies.
- Early recognition and intervention in the pediatric population are essential to mitigate long-term kidney damage.
- Further research into SCN susceptibility factors can inform preventative measures and treatment approaches.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
58
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
49
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
71
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
109
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
109
01:25Chronic Kidney Disease I: Introduction
307
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
307